ID22045A - Senyawa-senyawa trisiklik yang berguna untuk penghambatan fungsi protein-g dan untuk pengobatan penyakit-penyakit proliferatif - Google Patents

Senyawa-senyawa trisiklik yang berguna untuk penghambatan fungsi protein-g dan untuk pengobatan penyakit-penyakit proliferatif

Info

Publication number
ID22045A
ID22045A IDW990090D ID990090D ID22045A ID 22045 A ID22045 A ID 22045A ID W990090 D IDW990090 D ID W990090D ID 990090 D ID990090 D ID 990090D ID 22045 A ID22045 A ID 22045A
Authority
ID
Indonesia
Prior art keywords
protein
functions
treatment
protection
proliferative diseases
Prior art date
Application number
IDW990090D
Other languages
English (en)
Inventor
Dinanath F Rane
Alan K Mallams
Arthur G Taveras
F George Njoroge
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ID22045A publication Critical patent/ID22045A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW990090D 1996-09-13 1997-09-11 Senyawa-senyawa trisiklik yang berguna untuk penghambatan fungsi protein-g dan untuk pengobatan penyakit-penyakit proliferatif ID22045A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71332696A 1996-09-13 1996-09-13

Publications (1)

Publication Number Publication Date
ID22045A true ID22045A (id) 1999-08-26

Family

ID=24865700

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990090D ID22045A (id) 1996-09-13 1997-09-11 Senyawa-senyawa trisiklik yang berguna untuk penghambatan fungsi protein-g dan untuk pengobatan penyakit-penyakit proliferatif

Country Status (21)

Country Link
EP (1) EP0927178B1 (id)
JP (1) JP3152438B2 (id)
KR (1) KR20000036059A (id)
CN (1) CN1237169A (id)
AT (1) ATE213736T1 (id)
AU (1) AU729810B2 (id)
BR (1) BR9712819A (id)
CA (1) CA2264569C (id)
CZ (1) CZ83499A3 (id)
DE (1) DE69710741T2 (id)
ES (1) ES2169420T3 (id)
HK (1) HK1018267A1 (id)
HU (1) HUP9904067A2 (id)
ID (1) ID22045A (id)
IL (1) IL128949A0 (id)
NO (1) NO991230L (id)
NZ (1) NZ334340A (id)
PL (1) PL332240A1 (id)
SK (1) SK33199A3 (id)
TR (1) TR199900561T2 (id)
WO (1) WO1998011096A1 (id)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
DE69928226T8 (de) 1998-01-21 2006-10-19 Millennium Pharmaceuticals, Inc., Cambridge Chemokin rezeptor antagonisten und verwendung
EP1047675A1 (en) 1998-01-21 2000-11-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
WO2005017160A2 (en) 2003-08-13 2005-02-24 Children's Hospital Medical Center Mobilization of hematopoietic cells
ATE524445T1 (de) 2005-06-23 2011-09-15 Merck Sharp & Dohme Benzocycloheptapyridine als inhibitoren der tyrosinkinase met
TW200813021A (en) 2006-07-10 2008-03-16 Merck & Co Inc Tyrosine kinase inhibitors
TW201024283A (en) 2008-12-01 2010-07-01 Targacept Inc Synthesis and novel salt forms of (R)-3-((E)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine
JP6959332B2 (ja) 2016-09-27 2021-11-02 ミッション セラピューティクス リミティド Usp30の阻害剤としての活性を有するシアノピロリジン誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2164717T3 (es) * 1993-10-15 2002-03-01 Schering Corp Compuestos triciclicos de sulfonamida utiles para inhibir la funcion de la proteina-g y para el tratamiento de enfermedades proliferativas.
DK0723538T3 (da) * 1993-10-15 2002-03-18 Schering Corp Tricykliske carbamatforbindelser, der er nyttige til inhibition af funktion af G-protein og til behandling af proliferative sygdomme
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them

Also Published As

Publication number Publication date
NZ334340A (en) 2000-09-29
AU729810B2 (en) 2001-02-08
TR199900561T2 (xx) 1999-06-21
ATE213736T1 (de) 2002-03-15
AU4337397A (en) 1998-04-02
BR9712819A (pt) 1999-11-23
EP0927178A1 (en) 1999-07-07
CA2264569A1 (en) 1998-03-19
ES2169420T3 (es) 2002-07-01
EP0927178B1 (en) 2002-02-27
CA2264569C (en) 2003-11-11
HK1018267A1 (en) 1999-12-17
KR20000036059A (ko) 2000-06-26
JP2000502727A (ja) 2000-03-07
NO991230D0 (no) 1999-03-12
DE69710741D1 (de) 2002-04-04
IL128949A0 (en) 2000-02-17
SK33199A3 (en) 1999-12-10
NO991230L (no) 1999-05-14
DE69710741T2 (de) 2002-10-24
JP3152438B2 (ja) 2001-04-03
CN1237169A (zh) 1999-12-01
CZ83499A3 (cs) 1999-07-14
WO1998011096A1 (en) 1998-03-19
PL332240A1 (en) 1999-08-30
HUP9904067A2 (hu) 2000-05-28

Similar Documents

Publication Publication Date Title
GEP20032869B (en) Alpha -Ketoamide Inhibitors of 20S Proteasome, Pharmaceutical Preparations Containing the Same and Methods for Treatment
GEP20012578B (en) (54) Heteroaryl Succinamides, Pharmaceutical Compositions Containing the Same and Methods for Treatment of the Diseases Caused by Metalloproteinase Activity
MX9603831A (es) Agentes antitromboticos.
GEP20032896B (en) 4-Aminothiazole Derivatives, Containing Them Pharmaceutical Compositions Inhibiting Cyclin-Dependent Kinases and Methods for Treatment
GEP20012388B (en) Metalloproteinase Inhibitors, Pharmaceutical Compositions on Their Base, Use and Methods for Obtaining and Intermediates
EP0863755A4 (en) ANTITHROMBOTIC DIAMINES
ID22045A (id) Senyawa-senyawa trisiklik yang berguna untuk penghambatan fungsi protein-g dan untuk pengobatan penyakit-penyakit proliferatif
PL319503A1 (en) Peptide compounds and their therapeutic application as inhibitors
DK0725790T3 (da) Substituerede tetra- og pentapeptidinhibitorer af proteinfarnesyltransferase
TR199700727T1 (xx) Farnesil transferaz�n�n yeni inhibit�rleri.
GEP20022824B (en) Antipicornaviral Compounds, Pharmaceutical Compositions Containing the Same and Methods for Treatment
PT736029E (pt) Sulfamatos de pseudofructopiranose anticonvulsivos
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
BG102553A (en) Thiol derivatives having metallopeptidase inhibitor activity
AU7270798A (en) Antithrombotic agents
AU5390900A (en) Potassium channel blocking agents
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
AU8900498A (en) Compounds and pharmaceutical compositions thereof for eliciting analgesic effects
AU7274198A (en) Antithrombotic agents
IL114646A0 (en) Method of inhibiting leukotriene biosynthesis
GEP20032923B (en) Sulphonamide Derivatives as Prodrugs of Aspartyl Protease Inhibitors, Pharmaceutical compositions containing the Same and Methods for Treatment